• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Podcast: This Week in Managed Care—FDA's Gottlieb Resigns and Other Health News

Podcast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included Scott Gottlieb, MD, resigning as FDA commissioner; Eli Lilly offering a discounted version of Humalog; another study dispels the myths around autism and the measles, mumps, and rubella vaccine.

You may need to log in to the website to access this podcast.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

Dr Scott Gottlieb to Resign as FDA Commissioner

Lilly to Launch Half-Price Version of Humalog

What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee

HIV Compendium

In Wake of Measles Outbreaks, Another Study Dispels Myths Surrounding MMR Vaccine

HIV, Vaccine Refusal, Delays Among Greatest Threats to Global Health, Says WHO

AJMC®—March 2019

Common Elements in Opioid Use Disorder Guidelines for Buprenorphine Prescribing

Read more about the stories in this podcast:

Related Videos
Dr Jessica Robinson-Papp
Dr. Jessica Robinson-Papp
Dr. Robinson-Papp
Eneline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA
Related Content
Estimating Hidden Populations of HIV With an Advanced Capture-Recapture Model

Estimating Hidden Populations of HIV With an Advanced Capture-Recapture Model

November 23rd 2023
Article

The Targeted Minimum Loss-based Estimation proved the most accurate capture-recapture model in estimating hidden populations of patients with HIV.

Read More

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 2

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 2

November 21st 2023
Podcast

In part 2 of this 2-part podcast, a panel of experts discusses implementation biosimilars in biologic-naïve patients, auto-substitution, and more.

Listen

Human brain digital illustration. Electrical activity, flashes and lightning on a blue background. | Image credit: Siarhei - stock.adobe.com

HIV Infection Could Affect Individual’s IQ Score

November 14th 2023
Article

IQ score could be detrimentally influenced by an individual’s HIV infection, both through neurons and the gut.

Read More

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1

Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1

November 10th 2023
Podcast

In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.

Listen

PrEP Training During Residency Increased Knowledge of HIV

PrEP Training During Residency Increased Knowledge of HIV

November 10th 2023
Article

Residents grew more knowledgeable and more comfortable with using pre-exposure prophylaxis (PrEP) drugs for prevention against HIV after training was included in their residency program.

Read More

What We’re Reading: Free HIV Medication; MA Anticompetitive Regulations; Surge in Syphilis Cases

What We’re Reading: Free HIV Medication; MA Anticompetitive Regulations; Surge in Syphilis Cases

November 8th 2023
Article

Medicare may cover full cost of preexposure prophylaxis drugs; rules aim to prevent excessive compensation in Medicare Advantage (MA) market; health officials advocate for widespread syphilis testing and intervention.

Read More

© 2023 MJH Life Sciences
AJMC®
All rights reserved.